Literature DB >> 15102920

Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN.

Ke Ning1, Lin Pei, Mingxia Liao, Baosong Liu, Yunzhou Zhang, Wen Jiang, John G Mielke, Lei Li, Yonghong Chen, Youssef H El-Hayek, Michael G Fehlings, Xia Zhang, Fang Liu, James Eubanks, Qi Wan.   

Abstract

The tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a lipid and protein phosphatase. We report here that PTEN physically associates with the NR1 and NR2B subunits of NMDA receptors (NMDARs) in rat hippocampus. Downregulating the protein expression of PTEN inhibits the function of extrasynaptic NMDARs and decreases NMDAR surface expression, suggesting a crucial role for endogenous PTEN in the modulation of NMDAR-mediated neuronal function. Reducing PTEN expression also enhances Akt/Bad phosphorylation in hippocampal neurons. Importantly, suppressing lipid and protein phosphatase activity of PTEN, respectively, activates Akt and inhibits extrasynaptic NMDAR activity and thereby protects against ischemic neuronal death in vitro and in vivo. Thus, our study reveals a dual neuroprotective mechanism by which Akt/Bad and extrasynaptic NMDARs are regulated via downregulation of two distinct PTEN phosphatase activities and present the possibility of PTEN as a potential therapeutic target for stroke treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102920      PMCID: PMC6729419          DOI: 10.1523/JNEUROSCI.5449-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

Review 1.  Role of phosphoinositides at the neuronal synapse.

Authors:  Samuel G Frere; Belle Chang-Ileto; Gilbert Di Paolo
Journal:  Subcell Biochem       Date:  2012

2.  The PTEN phosphatase is essential for long-term depression of hippocampal synapses.

Authors:  Yue Wang; Aiwu Cheng; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  MicroRNA-26b/PTEN Signaling Pathway Mediates Glycine-Induced Neuroprotection in SAH Injury.

Authors:  Xingping Qin; Farhana Akter; Lingxia Qin; Qiurong Xie; Xinyu Liao; Rui Liu; Xueting Wu; Nina Cheng; Lingmin Shao; Xiaoxing Xiong; Renzhong Liu; Qi Wan; Songlin Wu
Journal:  Neurochem Res       Date:  2019-10-14       Impact factor: 3.996

4.  Role of Nogo-A in neuronal survival in the reperfused ischemic brain.

Authors:  Ertugrul Kilic; Ayman ElAli; Ulkan Kilic; Zeyun Guo; Milas Ugur; Unal Uslu; Claudio L Bassetti; Martin E Schwab; Dirk M Hermann
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

Review 5.  Is Cytoplasmic PTEN a Specific Target for Neuronal Survival?

Authors:  Anand Krishnan; Douglas W Zochodne
Journal:  Mol Neurobiol       Date:  2014-11-09       Impact factor: 5.590

6.  Possible Involvement of PTEN Signaling Pathway in the Anti-apoptotic Effect of Electroacupuncture Following Ischemic Stroke in Rats.

Authors:  Ying Xing; Man-Man Wang; Ya-Shuo Feng; Fang Dong; Feng Zhang
Journal:  Cell Mol Neurobiol       Date:  2018-08-22       Impact factor: 5.046

7.  Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death.

Authors:  Brendan Lujan; Xiaoxuan Liu; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

8.  Regulation of GABAA receptors by fragile X mental retardation protein.

Authors:  Baosong Liu; Lijun Li; Juan Chen; Zefen Wang; Zhiqiang Li; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

9.  Critical role of neuronal pentraxin 1 in mitochondria-mediated hypoxic-ischemic neuronal injury.

Authors:  Md Al Rahim; Shabarish Thatipamula; Mir Ahamed Hossain
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

10.  Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons.

Authors:  Oscar Diaz-Ruiz; Agustin Zapata; Lufei Shan; YaJun Zhang; Andreas C Tomac; Nasir Malik; Fidel de la Cruz; Cristina M Bäckman
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.